QGEN / QIAGEN (QGEN) Acquires the Forensics NGS Firm Verogen

In an increasingly challenging macro environment, QIAGEN (QGEN) surpasses the earnings and revenue outlook in the third quarter of 2023. more_horizontal

Although the revenue and EPS for Qiagen (QGEN) give a sense of how its business performed in the quarter ended September 2023, it might be worth consi more_horizontal

Qiagen (QGEN) came out with quarterly earnings of $0.50 per share, beating the Zacks Consensus Estimate of $0.49 per share. This compares to earnings more_horizontal

Investors are optimistic about QIAGEN's (QGEN) growth in the molecular diagnostics business and the latest acquisition. more_horizontal

QIAGEN's (QGEN) new QIAwave kits broaden its selection of environmentally friendly products and reaffirm its commitment to helping researchers advance more_horizontal

Qiagen NV (NYSE:QGEN ) Q2 2023 Earnings Conference Call August 9, 2023 9:00 AM ET Company Participants John Gilardi - VP, Corporate Communications & I more_horizontal

QIAGEN (QGEN) surpasses the earnings and revenue outlook in the second quarter of 2023 amid a challenging macro environment. more_horizontal

Qiagen (QGEN) came out with quarterly earnings of $0.51 per share, beating the Zacks Consensus Estimate of $0.50 per share. This compares to earnings more_horizontal